The effects of improving sleep on mental health (OASIS): a randomised controlled trial with mediation analysis

Freeman, Daniel and Sheaves, Bryony and Goodwin, Guy M. and Yu, Ly-Mee and Nickless, Alecia and Harrison, Paul J. and Emsley, Richard and Luik, Annemarie I. and Foster, Russell G. and Wadekar, Vanashree and Hinds, Christopher and Gumley, Andrew and Jones, Ray and Lightman, Stafford and Jones, Steve and Bentall, Richard and Kinderman, Peter and Rowse, Georgina and Brugha, Traolach and Blagrove, Mark and Gregory, Alice M . and Fleming, Leanne and Walklet, Elaine and Glazebrook, Cris and Davies, E. Bethan and Hollis, Chris and Haddock, Gillian and John, Bev and Coulson, Mark and Fowler, David and Pugh, Katherine and Cape, John and Moseley, Peter and Brown, Gary and Hughes, Claire and Obonsawin, Marc and Coker, Sian and Watkins, Edward and Schwannauer, Matthas and MacMahon, Kenneth and Siriwardena, A Niroshan and Espie, Colin A. (2017) The effects of improving sleep on mental health (OASIS): a randomised controlled trial with mediation analysis. The Lancet Psychiatry . ISSN 2215-0366

Full content URL: http://thelancet.com/pdfs/journals/lanpsy/PIIS2215...

Documents
The effects of improving sleep on mental health (OASIS): a randomised controlled trial with mediation analysis
Published online.
[img]
[Download]
[img]
Preview
PDF
Freeman OASIS LP 2017.pdf - Whole Document
Available under License Creative Commons Attribution 4.0 International.

509kB
Item Type:Article
Item Status:Live Archive

Abstract

Summary
Background: Sleep difficulties might be a contributory causal factor in the occurrence of mental health problems. If this is true, improving sleep should benefit psychological health. We aimed to determine whether treating insomnia leads to a reduction in paranoia and hallucinations.

Methods: We did this single-blind, randomised controlled trial (OASIS) at 26 UK universities. University students with insomnia were randomly assigned (1:1) with simple randomisation to receive digital cognitive behavioural therapy (CBT) for insomnia or usual care, and the research team were masked to the treatment. Online assessments took place at weeks 0, 3, 10 (end of therapy), and 22. The primary outcome measures were for insomnia, paranoia, and hallucinatory experiences. We did intention-to-treat analyses. The trial is registered with the ISRCTN registry, number ISRCTN61272251.

Findings: Between March 5, 2015, and Feb 17, 2016, we randomly assigned 3755 participants to receive digital CBT for insomnia (n=1891) or usual practice (n=1864). Compared with usual practice, the sleep intervention at 10 weeks reduced insomnia (adjusted difference 4·78, 95% CI 4·29 to 5·26, Cohen’s d=1·11; p<0·0001), paranoia (–2·22, –2·98 to –1·45, Cohen’s d=0·19; p<0·0001), and hallucinations (–1·58, –1·98 to –1·18, Cohen’s d=0·24; p<0·0001).
Insomnia was a mediator of change in paranoia and hallucinations. No adverse events were reported.

Interpretation: To our knowledge, this is the largest randomised controlled trial of a psychological intervention for a mental health problem. It provides strong evidence that insomnia is a causal factor in the occurrence of psychotic experiences and other mental health problems. Whether the results generalise beyond a student population requires testing. The treatment of disrupted sleep might require a higher priority in mental health provision.

Keywords:insomnia, mental health, paranoia, hallucinations, randomised controlled trial, cognitive behavioural therapy for insomnia, university students
Subjects:A Medicine and Dentistry > A300 Clinical Medicine
C Biological Sciences > C841 Health Psychology
C Biological Sciences > C860 Neuropsychology
Divisions:College of Social Science > School of Health & Social Care
ID Code:28668
Deposited On:13 Sep 2017 14:28

Repository Staff Only: item control page